Clinical Trial Update: Randomised, Double-blind Study to Investigate the Safety and Efficacy of Brotizolam in Insomnia Outpatients. [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind trial evaluating Brotizolam for safety and efficacy in adults with sleep initiation and maintenance disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sleep Initiation Disorders
• Sleep Maintenance Disorders

Drugs mentioned

• Brotizolam (brotizolam)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Sleep Initiation and Maintenance Disorders | Phase 3 | Status: COMPLETED